Rare titin-truncating variants are significantly enriched in patients with early-onset lone atrial fibrillation compared to healthy controls (OR 36.8).
Case-Control (n=770)
Do titin-truncating variants increase the risk of atrial fibrillation in patients with familial or early-onset lone AF?
Rare truncating variants in the sarcomeric protein titin are significantly associated with familial and early-onset atrial fibrillation, suggesting a genetic predisposition to structural atrial changes.
Odds Ratio: 36.8 (95% CI 5–4692.5)
Tasa de eventos absoluta: 4.7% vs 0%
valor p: p=4.13 x 10^-6
Abstract A family history of atrial fibrillation constitutes a substantial risk of developing the disease, however, the pathogenesis of this complex disease is poorly understood. We perform whole-exome sequencing on 24 families with at least three family members diagnosed with atrial fibrillation (AF) and find that titin-truncating variants (TTNtv) are significantly enriched in these patients ( P = 1.76 × 10 −6 ). This finding is replicated in an independent cohort of early-onset lone AF patients ( n = 399; odds ratio = 36.8; P = 4.13 × 10 −6 ). A CRISPR/Cas9 modified zebrafish carrying a truncating variant of titin is used to investigate TTNtv effect in atrial development. We observe compromised assembly of the sarcomere in both atria and ventricle, longer PR interval, and heterozygous adult zebrafish have a higher degree of fibrosis in the atria, indicating that TTNtv are important risk factors for AF. This aligns with the early onset of the disease and adds an important dimension to the understanding of the molecular predisposition for AF.
Ahlberg et al. (Thu,) conducted a case-control in Atrial fibrillation (n=770). Titin-truncating variants (TTNtv) vs. Non-carriers / Healthy controls was evaluated on Early-onset lone atrial fibrillation (OR 36.8, 95% CI 5.0-4692.5, p=4.13 x 10^-6). Rare titin-truncating variants are significantly enriched in patients with early-onset lone atrial fibrillation compared to healthy controls (OR 36.8).